Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from EchoIQ Limited ( (AU:EIQ) ) is now available.
Echo IQ Limited has issued 1,275,000 fully paid ordinary shares following the exercise of unlisted options priced at $0.25 and expiring on 14 June 2027, with the new shares forming part of its existing class of securities quoted on the ASX. The company confirmed that the issuance was conducted without a prospectus under the Corporations Act’s exemption provisions, and that it remains compliant with its financial reporting and continuous disclosure obligations, indicating a routine capital structure adjustment with no undisclosed information for investors.
The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.40 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ Limited is an Australian AI and medical technology company based in Sydney that uses AI-driven technology and proprietary software to improve decision-making in cardiology. Its solutions focus on enhancing cardiac diagnostic processes, positioning the company within the intersection of healthcare and advanced analytics.
Average Trading Volume: 1,467,065
Technical Sentiment Signal: Buy
Current Market Cap: A$247.1M
For detailed information about EIQ stock, go to TipRanks’ Stock Analysis page.